Hs-Troponin Elevation After Endurance Events: When the Post-Marathon Bump Is Physiologic Drift, When It Triggers the Cardiology Referral, and How the Sports RD Documents the Read Without Owning a Diagnosis Outside Scope
A 41-year-old marathoner presents to the sports RD three days after his goal race with a hs-cTnI of 118 ng/L flagged on an urgent-care panel he pulled because his post-race calf edema had him worried. His referring physician has read the elevation as "probably normal for the effort" and sent him for a diet consult. The sports RD is not the clinician who owns the cardiac differential — that is cardiology — but the sports RD is the professional the athlete trusts to read the panel in the context of the training load, and the sports RD is the one who has to know when the post-endurance troponin bump is the expected physiologic drift documented in the exercise-cardiology literature and when the same number in a different clinical picture opens the acute-coronary-syndrome differential the athlete needs cardiology on the same week. This is the hs-troponin-in-athletes interpretation guide for the sports RD: the reference ranges and the sex-specific 99th-percentile cutoffs, the exercise-induced elevation timeline and the six-to-twenty-four-hour peak, the four decision-tree branches the paired symptom-plus-lab picture opens, the specific red-flag symptoms that convert a physiologic reading into a cardiology-same-week referral regardless of the number, the SOAP-note structure that documents the RD's read and the specific referral question the cardiologist needs, and the reassessment loop with the paired troponin-plus-ECG cadence the sports-medicine team runs across the recovery week.
A 41-year-old amateur marathoner presents to the sports RD three days after his goal race with a high-sensitivity cardiac troponin I (hs-cTnI) of 118 ng/L flagged on an urgent-care panel he pulled the morning after the race because his post-race calf edema had him worried enough to walk into a same-day clinic. His referring physician has read the elevation as "probably normal for the effort" and sent him for a diet consult on the calf swelling. The athlete is asymptomatic for chest discomfort, has no shortness of breath outside of the expected post-race soreness pattern, has completed six prior marathons without a cardiac event, and has a family history that is negative for early cardiovascular death. He wants to know whether the number is something to worry about and whether he should be pushing for a cardiologist referral before his next training block.
This is the pattern the sports RD has to know how to read. The sports RD is not the clinician who owns the cardiac differential — that is cardiology, and any acute-coronary-syndrome workup runs through the emergency department or the cardiology consult, not through the sports-nutrition visit. But the sports RD is the professional the athlete has the ongoing relationship with, the one who reads the lab in the context of the training load, and the one who is best positioned to identify when the exercise-induced troponin elevation is the well-documented physiologic pattern the exercise-cardiology literature has described across the last two decades and when the same number in a different clinical picture opens the cardiology-same-week referral the athlete needs before another training block loads. Reading the number without the context is the failure mode on both sides — the physician reading it as "probably normal" without the training-load and symptom overlay, and the athlete reading a flagged panel as evidence of an acute cardiac event when the pattern is expected physiology.
This post is the hs-troponin interpretation guide for the sports RD who works with endurance athletes: the assay-specific reference ranges and the sex-specific 99th-percentile cutoffs, the exercise-induced elevation timeline and the six-to-twenty-four-hour peak the sports-cardiology literature has documented, the four decision-tree branches the paired symptom-plus-lab picture opens, the specific red-flag symptoms that convert a physiologic reading into a cardiology-same-week referral regardless of the number, the SOAP-note structure that documents the RD's read and the specific referral question the cardiologist needs, and the reassessment loop with the paired troponin-plus-ECG cadence the sports-medicine team runs across the recovery week.
Why the Post-Endurance Troponin Elevation Is Not a Coronary Event in Most Athletes
Cardiac troponin I and T are cardiomyocyte-specific structural proteins that circulate at low picogram-per-liter concentrations in healthy adults and rise on cardiomyocyte membrane injury of any etiology. The classical clinical use of the marker is in acute-coronary-syndrome workup, where an elevated troponin with a rising-and-falling pattern across serial draws, in the context of ischemic chest pain and ST-segment or T-wave changes on ECG, meets the Fourth Universal Definition of Myocardial Infarction criteria and drives the patient into the acute-coronary catheterization pathway.
The exercise-induced troponin elevation is a separate phenomenon that has been documented across three decades of endurance-sport cardiology research. Meta-analytic synthesis of the post-marathon, post-ultramarathon, post-Ironman, and post-long-distance-cycling literature shows detectable troponin elevation in 40 to 90 percent of finishers depending on the assay generation, the event distance and duration, the ambient temperature, the athlete's training-load ratio, and the timing of the draw. The elevation is not evidence of ischemic myocardial injury in the coronary-syndrome sense. It is a marker of reversible cardiomyocyte membrane permeability under the sustained hemodynamic and metabolic stress of prolonged endurance exertion — a signal that cardiomyocytes have released cytoplasmic troponin without the structural cell-death pattern that defines infarction.
The timeline distinguishes the physiologic pattern from the ischemic pattern. Exercise-induced troponin peaks 3 to 6 hours after event completion, remains detectable at 24 hours in most athletes, and returns to baseline by 48 to 72 hours in the overwhelming majority. The rise is single-peaked without the sustained plateau or the recurrent rise that acute ischemic injury produces. Serial draws at 6 hours and 24 hours after the event, with a return-to-baseline draw at 72 to 96 hours, produce the trajectory the sports-cardiology reader is looking for. A troponin that has not returned to baseline by 96 hours, or that has risen further across the 24-to-48-hour window, is the pattern that shifts the read out of expected physiology and toward the pathologic differential the cardiologist has to hold.
The Assay-Specific Reference Ranges the RD Needs to Read
The RD does not order the troponin panel — the ordering happens through the referring physician or the urgent-care or emergency-department workup that produced the reading. But the RD does read the number as it appears on the panel, and the reading is assay-specific in ways that are easy to miss. Two things to hold:
Hs-cTnI (high-sensitivity cardiac troponin I). The 99th-percentile upper reference for healthy adults is sex-specific: approximately 34 ng/L for males and 16 ng/L for females on the most commonly used contemporary assays (Abbott ARCHITECT, Beckman Access), with meaningful inter-assay variation. The manufacturer-and-lab-specific cutoff is the number that appears on the report and is the reference the reader should use, not a memorized universal cutoff. A value that reads as flagged on one lab's panel may sit within reference on another lab running a different assay.
Hs-cTnT (high-sensitivity cardiac troponin T). The 99th-percentile upper reference is approximately 14 to 22 ng/L on the Roche Elecsys assay depending on the reference population; some newer assays report sex-specific cutoffs, most do not. Hs-cTnT is more subject to skeletal-muscle cross-reactivity in the setting of neuromuscular disease and post-rhabdomyolysis presentations than hs-cTnI, though both are cardiac-specific in the healthy adult population.
The absolute value alone does not determine the clinical action. A hs-cTnI of 118 ng/L in the case that opened this post — roughly 3.5 times the 99th-percentile male reference — is a value that, in an emergency-department chest-pain presentation with ischemic ECG changes, would meet Universal Definition criteria for myocardial injury. In an asymptomatic 41-year-old marathoner drawn 72 hours after a goal marathon, the same value falls squarely inside the exercise-induced elevation range documented in the post-marathon cardiology literature and does not carry the same clinical action. Context is the interpretation, not the number in isolation.
The Timeline Read
The timing of the draw against the event completion is the second interpretive variable the RD has to capture at the intake. The reference reads:
- Immediate post-event (0-3 hours). Elevation is beginning; the peak is still ahead. A normal draw at this point does not rule out the physiologic elevation because the pattern has not yet fully developed.
- Peak window (3-6 hours after event). The physiologic elevation reaches its maximum. A draw in this window that shows a hs-cTnI above 100 ng/L is within the documented range for a well-trained endurance athlete completing a marathon or longer event; the reading needs to be interpreted against the athlete's baseline (if known) and the presence or absence of symptoms.
- 24 hours post-event. The elevation should be beginning to decline. A rising or plateaued value at 24 hours is the pattern that shifts the read toward pathologic rather than physiologic.
- 48-72 hours. Approaching or at baseline in the physiologic pattern. Values still substantially elevated at this window warrant paired-panel reassessment and cardiology consultation.
- Beyond 96 hours. Should be at baseline in the physiologic pattern. Persistent elevation is not physiologic and drives the cardiology workup regardless of symptom pattern.
The athlete in the opening case pulled his panel roughly 72 hours after event completion. A hs-cTnI of 118 ng/L at 72 hours is the trajectory point that starts to sit at the edge of the expected physiologic range. It is not by itself a call to the cardiologist for a same-day referral, but it is a value that warrants a paired-timing recheck to confirm the return-to-baseline trajectory before the athlete resumes structured training.
The Four Decision-Tree Branches
The paired symptom-plus-lab-plus-timeline picture opens four decision branches:
Branch 1: Asymptomatic, elevated troponin within physiologic-elevation range, timing consistent with post-event window, no ECG abnormalities. The read is expected physiology. Plan: reassessment troponin at 72 hours (if the current draw is earlier) to confirm return-to-baseline trajectory, no training resumption until the recheck confirms the trajectory, no cardiology referral in the absence of other signals. The RD documents the read, the timing, the training-load context, and the reassessment plan in the SOAP note and communicates to the referring physician.
Branch 2: Symptomatic with chest discomfort, dyspnea disproportionate to expected post-race recovery, palpitations, syncope, or presyncope — regardless of the troponin value. Same-day cardiology referral or emergency-department evaluation. The RD does not manage this in the outpatient nutrition visit. The symptom pattern is the driver, not the number. A troponin of 20 ng/L in a symptomatic athlete is a cardiology referral; a troponin of 300 ng/L in an asymptomatic athlete at 6 hours post-marathon may not be.
Branch 3: Elevated troponin persisting beyond 96 hours post-event, or rising across serial 24-hour and 48-hour draws. Cardiology consultation regardless of symptom pattern. The trajectory is the pathologic-versus-physiologic discriminator; a trajectory that does not fit physiologic drift needs the workup that the RD is not qualified to complete.
Branch 4: Elevated troponin, no clear event context. The athlete presents with a flagged troponin from an incidental panel without a preceding endurance event or without the timing that would explain the elevation. Cardiology consultation. This is not the sports-RD workup; the differential includes silent ischemia, myocarditis, arrhythmia, and structural heart disease, and the workup requires ECG, echocardiography, and cardiology-specific evaluation.
The Symptom Overlay That Overrides the Number
The symptom overlay is the piece of the workup the RD is best positioned to capture because the RD has the ongoing relationship and the athlete is more forthcoming in the nutrition visit than in a five-minute urgent-care encounter. The red-flag symptoms that convert any elevated troponin into a same-week cardiology referral:
Chest discomfort of any character. Not just the classic substernal pressure — atypical presentations including epigastric burning, jaw or arm radiation, or a persistent "tightness" the athlete cannot localize precisely. Endurance athletes tend to minimize or attribute discomfort to musculoskeletal sources, so the intake question should be open-ended: any unusual chest sensation during or after the event.
Dyspnea disproportionate to expected recovery. Endurance athletes have a well-developed sense of their own respiratory recovery pattern. Shortness of breath that does not resolve on the expected timeline, or that recurs with mild exertion during the recovery week, is a signal.
Palpitations, especially sustained or recurrent. Isolated ectopic beats during the recovery week are common and generally benign in the healthy endurance athlete. Sustained tachyarrhythmias, sustained bradyarrhythmias below the athlete's usual resting range, or recurrent palpitations that the athlete describes as "fluttery" or "skipping" are signals.
Syncope or presyncope, especially with exertion. Any near-syncope during exertion in an athlete with an elevated troponin is a same-day cardiology-or-emergency-department referral. The differential includes structural cardiac disease and arrhythmic events that must be worked up before training resumes.
Persistent or unusual fatigue. Endurance athletes expect fatigue in the recovery week. Fatigue that is unusually severe, that persists beyond the athlete's typical recovery timeline, or that is associated with any of the above symptoms shifts the read.
Any of the above, regardless of the troponin value, is the trigger for a same-week cardiology consultation. The RD documents the symptom, communicates the pattern to the referring physician, and requests the cardiology referral through the appropriate pathway.
The SOAP Documentation
The SOAP note has to capture the paired read — the number, the timing against the event, the symptom overlay, and the trajectory the reassessment plan is designed to confirm. My assessment-line structure on this pattern reads: "Post-endurance-event hs-cTnI elevation, [value] ng/L drawn [hours] after [event and distance] completion, sex-specific 99th-percentile reference [value] ng/L, timing and value consistent with documented physiologic post-endurance cardiomyocyte membrane permeability pattern. Asymptomatic for chest discomfort, dyspnea disproportionate to recovery, palpitations, syncope, or unusual fatigue on structured symptom review. No prior cardiac history, no family history of early cardiovascular death, no ECG abnormalities on the current workup. Physiologic-drift differential holds pending trajectory confirmation on paired reassessment draw at 96 hours post-event."
The plan documents five elements: no training resumption pending the reassessment; reassessment troponin (same assay, same lab where possible to eliminate cross-assay interpretive noise) at the 96-hour post-event mark; structured symptom-tracking checklist for the athlete to complete daily during the reassessment window, with the five red-flag symptoms above named explicitly and the escalation pathway (call the sports-medicine on-call physician, present to the emergency department for any chest pain or syncope) documented in the athlete's copy of the plan; nutrition plan for the recovery week that supports the physiologic recovery without loading a return-to-training stimulus that could confound the trajectory; and a communication to the referring physician that names the physiologic-elevation differential, the reassessment cadence, and the specific request that the physician be looped in on the 96-hour result so the training-resumption decision is made jointly.
The assessment does not conclude a diagnosis the RD is not qualified to conclude. It documents the working differential, the reasoning that supports the physiologic read, the safety net that catches the pattern if the differential is wrong, and the joint-decision framework for training resumption. This is the documentation standard that protects the athlete, protects the RD's scope, and gives the cardiologist (if the referral escalates) a document that starts the visit at the correct point.
The Reassessment Loop
At 96 hours post-event the paired reassessment draws the same troponin, the same lab, and adds a symptom-tracking review with the athlete. The physiologic-elevation branch closes cleanly on three findings: the troponin has returned to baseline (either the athlete's known baseline or within the assay reference); the symptom tracker across the recovery week has been unremarkable; and the athlete reports the expected recovery trajectory without new symptoms. The training-resumption plan proceeds through a structured return-to-training progression that the sports-medicine team coordinates — typically a two-to-three-week ramp with load monitoring and a follow-up nutrition visit at week 4 to review the ramp response.
The pathologic-differential branch opens on any of three findings: the troponin has not returned to baseline; the symptom tracker has captured any red-flag symptom during the window; or the athlete reports an atypical recovery pattern. The cardiology referral proceeds with the SOAP note, the reassessment trajectory, and the symptom-tracker documentation attached. The RD holds the interim relationship — training is on hold, the fueling plan is maintained at a maintenance level rather than a training-supporting level, and the athlete is seen weekly by the RD until the cardiology workup produces a diagnosis or a clearance.
The Prevention Layer the RD Contributes
The sports RD's role in the post-endurance-event troponin workup is not limited to the reactive interpretation of a flagged panel. The RD contributes to the prevention layer that reduces the frequency and magnitude of the physiologic-elevation pattern and, more importantly, reduces the athlete's risk of the pathologic-elevation pattern the physiologic drift can mask.
The prevention-layer elements the RD owns:
Adequate carbohydrate availability across the taper and race. Glycogen depletion increases the metabolic and hemodynamic stress the cardiomyocyte experiences during prolonged exertion. Athletes who arrive at the starting line with suboptimal carbohydrate loading show larger post-event troponin elevations in the observational literature. The RD's pre-event fueling plan is a cardiac-stress-reduction intervention as much as a performance intervention.
Hydration and sodium management across the event. Volume depletion and hyponatremia both increase cardiac stress during long-duration events. The RD's individualized hydration plan, calibrated to sweat-rate testing and event conditions, is another cardiac-load-reduction element.
Training-load and event-selection audit. Athletes attempting event distances significantly beyond their training preparation show the largest post-event troponin elevations. The RD's role in the pre-event planning is to identify the athletes whose training-to-event-distance mismatch would predict a large elevation and, in coordination with the coach, to advise the fueling plan against the realistic-ceiling event target rather than the aspirational-ceiling target.
Iron status and hemoglobin optimization. Iron-deficient athletes recruit larger hemodynamic responses to maintain oxygen delivery under exertion, and the associated cardiac stress is measurable. The RD's iron-status intake and correction protocol, run months in advance of goal events, is a cardiac-load intervention.
Baseline troponin documentation for masters athletes. A once-a-year baseline hs-cTnI drawn outside a training block and outside the post-event window is a useful reference for the masters-athlete population that will show the elevation pattern across multiple events per year. The baseline gives the reader something to interpret the flagged value against rather than reading against a population-derived 99th percentile that may not fit the individual athlete.
The Case-Pattern Prevalence and Why It Matters Now
The elevated-troponin post-endurance-event presentation shows up in the sports-RD referral base at a frequency that has risen across the last decade for three reasons that compound. The high-sensitivity assays now standard in outpatient and urgent-care laboratories detect elevations that older assays missed — a value that would have read below the detection floor on a fourth-generation assay reads as flagged on a fifth-generation assay, and the flagged panel drives the referral. The direct-to-consumer lab-testing market has put troponin panels on the same order sheet as basic metabolic panels for athletes who want a broader workup. And the growth of the amateur endurance-event market — marathons, half-marathons, gran-fondos, hyrox, spartan, ultramarathons, and the tactical-athlete equivalents — has increased the base rate of post-event athletes who pull panels within the elevation window.
Any sports RD taking on endurance-athlete cases should have the post-event troponin read on the intake checklist as a routine question: what labs have you drawn in the last 90 days, and were any values flagged. The workup this post describes is the read the RD needs to know how to run, and the referral pathway the RD needs to know how to open.
Where Calsanova Fits
The post-endurance-event troponin workup requires the intake to hold the training-load history, the event calendar, the paired lab-and-symptom review, the reassessment schedule, and the interdisciplinary handoff to cardiology when the trajectory does not fit. Calsanova's clinical intake carries the training-load-plus-event-history capture at first visit, the lab-tracking module holds the paired timing-and-value entry with assay-specific 99th-percentile reference lookup at data entry, and the symptom-tracker template runs the five red-flag symptom set with automatic prompt-back to the athlete across the reassessment window. The interdisciplinary handoff format includes the cardiology-referral packet structure with the physiologic-versus-pathologic-differential reasoning already scaffolded so the sports RD is not authoring the referral document from scratch under time pressure.
Ready to move your sports-nutrition intake workflow into a purpose-built clinical system? Try Calsanova free for 30 days — no credit card, HIPAA-ready from day one, and the paired post-event troponin interpretation runs automatically on every lab entry with the reassessment schedule pre-populated against the athlete's recovery timeline.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
Soluble Transferrin Receptor (sTfR) and the sTfR / Log-Ferritin (Thomas) Index in the Heavily Trained Endurance-Athlete Iron Workup: Why Ferritin-Plus-CRP Is Not Enough When Chronic Training-Load Inflammation Sits Above the Reference, the Tissue-Iron-Demand Signal That the Acute-Phase Panel Cannot Confound, and the SOAP Structure That Carries the Index Into the Coordinated Iron-Deficiency Decision
A 26-year-old male competitive triathlete presents at the end of a 20-week Ironman build with an 8-week performance regression — threshold power 285W to 265W, submax heart rate up 7 bpm, flat HRV, no training-load or sleep explanation. Primary care panel returned ferritin 62 ng/mL and hs-CRP 4.8 mg/L — read by the physician as 'iron status normal, mild chronic inflammation consistent with endurance training, continue current training.' The read misses the question the presentation is actually asking: is the within-reference ferritin a genuine storage-pool signal or a chronic-training-inflammation-inflated signal that is masking iron-deficient erythropoiesis at the bone-marrow precursor level. Ferritin is a positive acute-phase reactant and the endurance athlete carrying a chronic hs-CRP of 3-to-6 mg/L for twenty weeks running has an inflation-inflated ferritin that the paired ferritin-plus-CRP discipline cannot cleanly discount — 'defer the iron workup until the off-season' is not an acceptable answer in the final 8 weeks of a competition build. The marker that sidesteps the acute-phase confounding is the soluble transferrin receptor (sTfR), and the interpretive instrument that pairs it against the storage pool is the Thomas index — sTfR divided by log(ferritin). This is the sTfR and Thomas index interpretation guide for the sports RD: what sTfR actually measures and why its biology is immune to the acute-phase-reactant confounding that distorts ferritin, why the chronic hs-CRP elevation that endurance training produces is precisely the population in which the paired ferritin-plus-CRP panel is insufficient, the Thomas index interpretive framework that separates true iron-deficient erythropoiesis from inflammation-inflated ferritin from compound presentations, the four intake presentations that should trigger the sTfR referral regardless of a within-reference ferritin, and the SOAP structure that carries the index into the iron-deficiency decision before the athlete's performance regression becomes a frank anemic presentation.
October 6, 2026
Fecal Calprotectin vs. Lactoferrin in the Endurance Athlete GI Workup: What the Sports RD Should Order, How to Read the Paired-Marker Pattern Against Training Load, and the SOAP Documentation Structure That Prevents Both the Missed IBD Diagnosis and the Unnecessary Scope Referral
GI complaints in endurance athletes routinely return with normal CBC, CMP, and stool guaiac panels that the primary reads as unremarkable. Fecal calprotectin and fecal lactoferrin, ordered as a pair on a recovery-window sample with training-log context, are the two neutrophil-derived stool markers that let a sports RD separate exercise-associated gut permeability from an actual inflammatory floor before the athlete either loses the season to a missed IBD diagnosis or gets scoped for an exercise-induced pattern that a nutrition intervention would have resolved. Here is the paired-marker interpretive framework, the athlete-specific reference bands, the 96-hour sample-timing discipline, and the SOAP structure that documents the escalation.
September 17, 2026
Hemoglobin, Hematocrit, and MCV Interpretation in Endurance Athletes: Why the Standard CBC Reference Ranges Read Trained Aerobic Athletes as Anemic When the Panel Is Actually Showing Plasma Volume Expansion, the Paired-Marker Discipline That Separates Pseudoanemia From Iron-Deficient Microcytic Anemia From Combined Deficiencies, and the SOAP Documentation Structure That Prevents the Unnecessary Iron Load and Keeps the Real Iron-Deficiency Signal From Being Masked
A 27-year-old male sub-elite road cyclist in week 9 of a 16-week base build presents to the sports RD with a routine CBC ordered by his primary reading hemoglobin 13.4 g/dL (flagged low against the 13.5-17.5 g/dL male reference), hematocrit 40.1 percent (flagged low against the 41-53 percent reference), MCV 89 fL (mid-normal), MCH and MCHC within reference, ferritin 68 ng/mL, and transferrin saturation 32 percent. The primary's note reads 'mild anemia, consider oral iron supplementation and recheck in three months.' The primary's read is the wrong read. The CBC is not showing anemia — it is showing plasma volume expansion, the reproducible physiologic adaptation of the trained aerobic athlete's cardiovascular system to sustained endurance training. Starting oral iron on the presenting picture pushes a well-adapted athlete into iron loading he does not need, masks the true iron-deficiency signal if it develops later in the season, and treats a lab flag rather than the athlete. The paired hemoglobin-hematocrit-plus-MCV-plus-iron-panel workup is the discipline that separates the four differential patterns — coupled pseudoanemia from plasma volume expansion, iron-deficient microcytic anemia, combined pseudoanemia with underlying iron deficiency, and the acute-training-response artifact — and the SOAP documentation that names the pattern explicitly is what keeps the athlete out of the wrong intervention. This is the paired-panel interpretation guide for the sports RD: what the CBC indices actually measure and why the general-population reference ranges misread the trained-athlete population, the athlete-specific interpretive framework built around MCV and the paired iron panel, the four presentations that should trigger the paired workup regardless of the CBC flag, the differential that separates the four patterns above with the specific numerical bands each occupies, the SOAP assessment structure that documents the plasma-volume-expansion-versus-iron-deficiency read so the primary conversation lands at the right question, and the paired mechanical-loading-plus-nutritional-intervention loop the sports RD holds across the 8-to-12-week reassessment cadence.
September 8, 2026